EGFR and non-small cell lung carcinoma: The objective of this analysis is to estimate the financial impact on the Greek National Health System of adopting an alternative, less invasive testing option of plasma-based EGFR mutation testing and to identify the most cost-optimal EGFR mutation testing approach to support treatment of patients diagnosed with NSCLC in Greece.